Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2019 - 03 - 11
点击次数: 0
Positions: President and CSO
Company: Akshaya Bio Inc.
个人简介:
Dr. Rajan George is the Founder, President and Chief Scientific Officer of Akshaya Bio Inc., a biotechnology company developing vaccines as well as other biotherapeutic agents.Previously, Dr. George was Executive Vice President and Chief Technology Officer of Paladin Biosciences, a division of Paladin Labs Inc. (TSX:PLB), Edmonton, Alberta, Canada. He holds Adjunct Faculty appointment in the Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. The focus is on the development of therapeutic vaccines for chronic viral infections such as Hepatitis B and Hepatitis C.Dr. George is the co-inventor of Chimigen® Vaccine Platform technology which received the Alberta Science and Technology award for innovation in 2004. He was the recipient of a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation in 2009. Dr. George was Senior Vice President of Research and Development and a founding member of ViRexx Medical Corp., (TSX:VIR, AMEX:REX), Edmonton, Alberta, Canada, before Paladin acquisition.Previously, a Research Scientist at the Glaxo Heritage Research Institute, University of Alberta, Edmonton, Canada, where the field of research was Hepatitis B virology and antiviral therapy. Dr. George received a Ph.D in Biochemistry from the Indian Institute of Sciences (Bangalore, India). He also had postdoctoral training at the University of Wisconsin in Madison, WI, USA and the University of Alberta (Edmonton, Alberta, Canada).
发布时间: 2019 - 03 - 11
点击次数: 0
Positions: General Manager / CSO / Vice President
Company: Beijing Minhai Biotechnology Co.,Ltd / Shenzhen Kangtai Biological Products Co., Ltd
个人简介:
郑海发,男,研究员,深圳康泰生物制品股份有限公司副总裁,北京民海生物科技有限公司总经理、首席科学家。国家第十一届药典委员会委员;重大新药创制专项、重大传染病专项评审专家;新型疫苗研制技术国家重点实验室主任;中华预防医学会生物制品分会委员;中华医学会微生物与免疫学分会委员;中国医药生物技术协会疫苗专业委员会委员;中国药学会生物药品与质量专业委员;中国药品监督管理研究会生物制品监督管理研究专业委员会委员;中科院过程所硕士导师。
发布时间: 2019 - 03 - 11
点击次数: 0
Positions: Founder & CEO
Company: BravoVax Co., Ltd
个人简介:
Dr. Wu Ke is the Founder and CEO of BravoVax. He has more than 30 years of experiences in biopharm industry and had successfully developed 7 products being approved by CFDA and marketed in China. He also has 30+ applications/granted patents from China or PCT.He was Executive President of Shanghai Zerun Biotechnology, in charge of management of QA/QC, Manufacture, R&D, Engineering and Maintenance, Regulatory Affairs, Marketing, also extensively experienced in business development, technology transfer, etc. Prior to start Zerun, he was Director of R&D in Wuhan Institute of Biological Products, China National Biotec Group (CNBG), in charge of development of new vaccines and blood products.He holds a PhD degree in Immunology, also alumnus of both China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB). He is a Guest Professor in several universities.
发布时间: 2019 - 03 - 11
点击次数: 0
Positions: CEO / CSO
Company: BIRD-C G-C GmbH & Co KG
个人简介:
Werner Lubitz , born in Wels, Austria, holds an MSc and a PhD in Microbiology from the Technical University of Munich, Germany. He obtained his postdoctoral training in Cell- and Tumor-Biology at the Institute of Cell Biology, University of Munich, Germany, at the Centre Hopitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, at the Wallenberg Laboratories, University of Uppsala, Sweden, at the Biocenter, University of Basel, Switzerland, and at the Max Plank Institute of Neurobiology, Martinsried, Germany, and in Genetic Engineering and Microbiology at the Institute of Microbiology, University of Victoria, Canada. Werner Lubitz was Associate Professor of Microbiology at the Institute of Microbiology, University of Kaiserslautern, Germany, and Associate Professor at the Institute of Genetics, University of Munich, Germany. Since 1987, he was Full Professor of Microbiology and Biotechnology at the University of Vienna, Austria, first at the Department of Microbiology, Genetics and Immunology, later at the Department of Medicinal Chemistry, University of Vienna, and the Center of Molecular Biology, Vienna Biocenter. He published more than 200 peer reviewed papers and holds an extensive patent portfolio. Werner Lubitz is the inventor of the Bacterial Ghost Platform Technology He is the founder and cofounder of three Biotech Companies and after retirement from the University of Vienna, 2010, he is the CEO of BIRD-C.